EHC — Encompass Health Corporation stock price, charts and financials

QT68Encompass Health Corporation

Encompass Health Corporation (NYSE: EHC) is a Healthcare company in the Medical - Care Facilities industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
121.75
-1.39-1.13%
EHCQT68Encompass Health Corporation·NYSE
121.75-1.13%
News
Down 1.1% — Here's Why Encompass Health (EHC) is a Strong Growth Stock (zacks.com).
Medium confidence
TA
Loading chart...
Screen all →
Snapshot
Index-P/E19.83EPS (ttm)6.14Insider Own1.73%Shs Outstand99.20MPerf Week0.03%
Market Cap12.01BForward P/E18.23EPS next Y6.68Insider Trans-13.93%Shs Float97.92MPerf Month0.01%
Enterprise Value14.78BPEG1.81EPS next Q1.38Inst Own-Short Float3.31%Perf Quarter24.20%
Income622.00MP/S1.95EPS this Y-0.44%Inst Trans-Short Ratio3.22Perf Half Y24.37%
Sales6.21BP/B3.49EPS next Y9.24%ROA8.33%Short Interest3.24MPerf YTD14.71%
Book/sh34.89P/C111.83EPS next 5Y10.94%ROE25.01%52W High128.00 -4.88%Perf Year-2.04%
Cash/sh1.09P/FCF29.21EPS past 3/5Y27.07% 14.22%ROIC13.37%52W Low92.77 31.24%Perf 3Y77.53%
Dividend Est.0.84 (0.69%)EV/EBITDA9.86Sales past 3/5Y10.92% 10.73%Gross Margin73.13%Volatility2.01% 1.96%Perf 5Y93.87%
Dividend TTM0.76 (0.62%)EV/Sales2.38EPS Y/Y TTM37.67%Oper. Margin18.00%ATR (14)2.62Perf 10Y270.62%
Dividend Ex-DateOct 01, 2026Quick Ratio1.19Sales Y/Y TTM15.52%Profit Margin10.01%RSI (14)53.50Recom2.19
Dividend Gr. 3/5Y-4.46% -4.71%Current Ratio1.19EPS Q/Q10.71%SMA200.27%Beta0.75Target Price150.25
Payout12.11%Debt/Eq0.83Sales Q/Q9.53%SMA502.99%Rel Volume1.47Prev Close123.14
Employees29,699LT Debt/Eq0.81EarningsOct 28SMA20013.17%Avg Volume982.33KPrice121.75
IPO DateSep 24, 1986Option/ShortYes / YesEPS/Sales Surpr.4.76% 1.66%Net Debt/EBITDA1.82Volume1,439,552Change-1.13%
Analyst Ratings
DateActionAnalystRatingTarget
Aug-07-26ReiteratedTruist SecuritiesBuy$140$150
Aug-07-26ReiteratedUBSBuy$150$155
Aug-06-26ReiteratedBarclaysOverweight$140$144
May-22-26ReiteratedLeerink Partners$152
May-05-26ReiteratedBarclaysOverweight$153$140
Feb-06-26ReiteratedBarclaysOverweight$150$153
Oct-30-25ReiteratedBarclaysOverweight$101$150
Oct-02-25ReiteratedUBSBuy$110$150
Aug-14-25ReiteratedTruist SecuritiesBuy$140
Apr-28-25ReiteratedRBC CapitalOutperform$105$125
Latest News· Times ET
Sep-18-26
Sep-17-26
Sep-15-26
Sep-07-26
Sep-04-26
Aug-30-26
Aug-28-26
Aug-26-26
Aug-25-26
Aug-24-26
Company

Encompass Health Corporation delivers a range of post-acute healthcare services across the United States, offered both in dedicated facilities and directly within patients' homes. The company's operations are divided into two primary divisions: Inpatient Rehabilitation, and Home Health and Hospice. Its Inpatient Rehabilitation division specializes in providing focused recovery treatment, available on an inpatient or outpatient basis. This care is designed for individuals recuperating from significant health challenges such as strokes, neurological disorders, cardiac and pulmonary issues, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment primarily serves the Southeast and Texas regions. Within this segment, home health services encompass a variety of Medicare-certified care options for adult patients, including skilled nursing, medical social work, home health aide assistance, and various therapies like physical, occupational, and speech therapy. Hospice services, on the other hand, provide in-home comfort and support for terminally ill patients and their families. As of June 1, 2022, Encompass Health maintained a substantial network, managing 149 hospitals, 252 home health locations, and 99 hospice locations spread across 42 U.S. states and Puerto Rico. The company, which established its roots in 1983 and is headquartered in Birmingham, Alabama, was formerly known as HealthSouth Corporation until its name change to Encompass Health Corporation in January 2018.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue6,2075,9355,373
Cost of Goods Sold Incl. D&A1,6682543,140
Gross Profit4,5395,6812,233
Selling, General and Administrative Excl. Other1,0613,411267
Research and Development
000
Other Operating Expense2,3611,2171,102
Operating Income1,1171,053865
Interest Expense126123137
Unusual Expense
Non-Operating Income (Expense)372323
Net Income Before Taxes1,029953750
Income Taxes210193150
Consolidated Net Income622566456
Net Income From Continuing Operations817760599
Net Income622566456
EPS (Recurring)6.225.624.53
EPS (Basic, Before Extraordinaries)6.225.624.53
EPS (Diluted)6.145.544.46
EBITDA1,5001,4041,187
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio19.8319.1620.71
Price To Sales Ratio1.941.811.72
Gross Margin73.1395.7241.56
Operating Margin18.0017.7416.10
Net Margin10.029.548.49
Shares Outstanding99101100
Market Capitalization12,05310,7209,235
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$132.18$121.34$110.50$99.67$88.83 Close Price0.00M6.61M13.22M19.82M26.43MUSD Trades VolumeSepOctNovDec2026FebMarAprMayJunJulAugSep
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Darby John PatrickEVP, Gen Counsel & SecretaryAug 31 '26Sale121.094,858588,25575,041Sep 01
Price Andrew LChief Accounting OfficerAug 31 '26Sale120.935,211630,16669,483Sep 01
Darby John PatrickEVP, Gen Counsel & SecretaryAug 31 '26Option Exercise35.064,858170,32179,899Sep 01
Darby John PatrickEVP, Gen Counsel & SecretaryAug 10 '26Sale125.958,9061,121,71175,041Aug 11
Tarr Mark JPresident & CEOAug 10 '26Sale125.47173,14821,724,096267,814Aug 11
COLTHARP DOUGLAS EEVP & Chief Financial OfficerAug 10 '26Sale125.3818,8692,365,79550,508Aug 11
COLTHARP DOUGLAS EEVP & Chief Financial OfficerMay 15 '26Option Exercise32.9427,694912,24097,071May 18
COLTHARP DOUGLAS EEVP & Chief Financial OfficerMay 15 '26Sale106.8327,6942,958,55069,377May 18
Tuer Patrick WilliamEVP, Chief Operating OfficerMay 11 '26Sale104.5668271,31024,755May 12
Fay EdmundSr. Vice Pres. and TreasurerMar 09 '26Sale107.0011,9371,277,25989,325Mar 10
Tarr Mark JPresident & CEOFeb 11 '26Sale111.64150,00016,746,689377,070Feb 12
Tuer Patrick WilliamEVP, Chief Operating OfficerFeb 10 '26Sale107.622,804301,76616,042Feb 10
Tuer Patrick WilliamEVP, Chief Operating OfficerAug 27 '25Sale123.591,020126,06218,846Aug 27
Tarr Mark JPresident & CEOMay 20 '25Sale121.53118,38414,387,152527,070May 20
Tarr Mark JPresident & CEOMay 20 '25Option Exercise40.10118,3844,747,112645,454May 20
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.